HK1201817A1 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme - Google Patents

Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Info

Publication number
HK1201817A1
HK1201817A1 HK15102227.4A HK15102227A HK1201817A1 HK 1201817 A1 HK1201817 A1 HK 1201817A1 HK 15102227 A HK15102227 A HK 15102227A HK 1201817 A1 HK1201817 A1 HK 1201817A1
Authority
HK
Hong Kong
Prior art keywords
ubiquitin
activating enzyme
pyrazolopyrimidinyl
inhibitors
pyrazolopyrimidinyl inhibitors
Prior art date
Application number
HK15102227.4A
Other languages
English (en)
Chinese (zh)
Inventor
Roushan Afroze
Indu T Bharathan
Jeffrey P Ciavarri
Paul E Fleming
Jeffrey L Gaulin
Mario Girard
Steven P Langston
Francois R Soucy
Tzu-Tshin Wong
Yingchun Ye
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of HK1201817A1 publication Critical patent/HK1201817A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK15102227.4A 2012-02-17 2015-03-05 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme HK1201817A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261600070P 2012-02-17 2012-02-17
PCT/US2013/026113 WO2013123169A1 (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Publications (1)

Publication Number Publication Date
HK1201817A1 true HK1201817A1 (en) 2015-09-11

Family

ID=48982730

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102227.4A HK1201817A1 (en) 2012-02-17 2015-03-05 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Country Status (30)

Country Link
US (4) US9290500B2 (es)
EP (3) EP3536692B1 (es)
JP (1) JP6122877B2 (es)
KR (1) KR20140123104A (es)
CN (1) CN104136399B (es)
AR (1) AR092797A1 (es)
BR (1) BR112014020365B1 (es)
CA (1) CA2864672C (es)
CL (1) CL2014002181A1 (es)
CO (1) CO7071135A2 (es)
CR (1) CR20140380A (es)
DO (1) DOP2014000187A (es)
EA (1) EA035020B1 (es)
EC (1) ECSP14019113A (es)
ES (1) ES2739150T3 (es)
GE (1) GEP201706687B (es)
HK (1) HK1201817A1 (es)
IL (1) IL234016A0 (es)
MA (1) MA35932B1 (es)
MX (1) MX352963B (es)
NZ (1) NZ628969A (es)
PE (1) PE20142244A1 (es)
PH (1) PH12014501832A1 (es)
SG (2) SG10201606581RA (es)
TN (1) TN2014000351A1 (es)
TW (1) TWI593688B (es)
UA (1) UA116534C2 (es)
UY (1) UY34629A (es)
WO (1) WO2013123169A1 (es)
ZA (1) ZA201406103B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
CN104136399B (zh) 2012-02-17 2018-08-07 米伦纽姆医药公司 泛素活化酶的吡唑并嘧啶基抑制剂
JP2015524442A (ja) 2012-08-03 2015-08-24 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Uba6のインドール置換ピロロピリミジニル阻害剤
WO2015002994A2 (en) 2013-07-02 2015-01-08 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
MY183649A (en) 2014-07-01 2021-03-05 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of sumo activating enzyme
TW201625256A (zh) 2014-10-29 2016-07-16 千禧製藥公司 泛素活化酶抑制劑及化療劑之投藥
JP6697453B2 (ja) 2014-10-29 2020-05-20 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. ユビキチン活性化酵素阻害物質及び放射線の投与
US11155560B2 (en) 2018-10-30 2021-10-26 Kronos Bio, Inc. Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity
WO2023021498A1 (en) * 2021-08-16 2023-02-23 Moya Bio Ltd. Fused azole and furan based nucleoside analogs and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2477795A1 (en) 2002-02-28 2003-09-12 Kandasamy Sakthivel Nucleoside 5'-monophosphate mimics and their prodrugs
JP2006501260A (ja) 2002-09-04 2006-01-12 シェーリング コーポレイション サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン
US7067661B2 (en) 2002-09-04 2006-06-27 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
US20070179161A1 (en) 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) * 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
US20050130974A1 (en) 2003-10-17 2005-06-16 Rigel Pharmaceuticals, Inc. Benzothiazole compositions and their use as ubiquitin ligase inhibitors
EP1758873A1 (en) 2004-06-22 2007-03-07 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
WO2006084281A1 (en) 2005-02-04 2006-08-10 Millennium Pharmaceuticals, Inc. Inhibitors of e1 activating enzymes
WO2007044426A2 (en) 2005-10-06 2007-04-19 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
WO2007092213A2 (en) 2006-02-02 2007-08-16 Millennium Pharmaceuticals, Inc. Inhibitors of e1 activating enzyme
CN101395698B (zh) * 2006-02-28 2010-06-09 兰姆研究股份公司 用于液体处理盘形物体的装置及方法
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
RS51549B (en) * 2006-08-08 2011-06-30 Millennium Pharmaceuticals Inc. HETEROARIL UNITS USEFUL AS INVESTIGATIVE ENZYME E1 INHIBITORS
TWI519508B (zh) 2007-06-12 2016-02-01 Achaogen Inc 抗菌劑
KR101925902B1 (ko) 2007-08-02 2018-12-06 밀레니엄 파머슈티컬스 인코퍼레이티드 E1 활성화 효소 억제제의 합성 방법
WO2009082691A1 (en) 2007-12-21 2009-07-02 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
UA108986C2 (uk) * 2009-05-14 2015-07-10 Мілленніум Фармасьютікалз, Інк. Кристалічна форма гідрохлориду ((1s,2s,4r)-4-{4-[(1s)-2,3-дигідро-1h-інден-1-іламіно]-7h-піроло[2,3-d]піримідин-7іл}-2-гідроксициклопентил)метилсульфамату (варіанти)
RU2581367C2 (ru) 2010-03-01 2016-04-20 Джи Ти Икс, ИНК. Соединения для лечения рака
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
EP2748168A4 (en) 2011-08-24 2015-04-22 Millennium Pharm Inc HEMMER OF NEDD8-ACTIVATING ENZYME
CN104136399B (zh) 2012-02-17 2018-08-07 米伦纽姆医药公司 泛素活化酶的吡唑并嘧啶基抑制剂
JP2015524442A (ja) 2012-08-03 2015-08-24 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Uba6のインドール置換ピロロピリミジニル阻害剤
WO2015002994A2 (en) 2013-07-02 2015-01-08 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
MY183649A (en) 2014-07-01 2021-03-05 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of sumo activating enzyme

Also Published As

Publication number Publication date
DOP2014000187A (es) 2014-10-15
AR092797A1 (es) 2015-05-06
EP3536692A1 (en) 2019-09-11
MA35932B1 (fr) 2014-12-01
KR20140123104A (ko) 2014-10-21
EP2814791A1 (en) 2014-12-24
BR112014020365B1 (pt) 2023-02-23
ECSP14019113A (es) 2015-09-30
EA201400831A1 (ru) 2014-12-30
EP2814791A4 (en) 2015-08-19
ZA201406103B (en) 2017-11-29
TWI593688B (zh) 2017-08-01
US20170217968A1 (en) 2017-08-03
NZ628969A (en) 2017-03-31
TN2014000351A1 (en) 2015-12-21
MX352963B (es) 2017-12-15
PH12014501832A1 (en) 2014-11-17
CN104136399A (zh) 2014-11-05
SG11201404757WA (en) 2014-09-26
US9796725B2 (en) 2017-10-24
PE20142244A1 (es) 2015-01-07
US20140088096A9 (en) 2014-03-27
JP6122877B2 (ja) 2017-04-26
GEP201706687B (en) 2017-06-26
CA2864672A1 (en) 2013-08-22
UA116534C2 (uk) 2018-04-10
CL2014002181A1 (es) 2014-12-12
SG10201606581RA (en) 2016-09-29
UY34629A (es) 2013-09-02
ES2739150T3 (es) 2020-01-29
CN104136399B (zh) 2018-08-07
JP2015508775A (ja) 2015-03-23
BR112014020365A2 (pt) 2020-12-22
US20170369499A1 (en) 2017-12-28
WO2013123169A1 (en) 2013-08-22
CO7071135A2 (es) 2014-09-30
EP3536692B1 (en) 2021-04-07
EA035020B1 (ru) 2020-04-17
CR20140380A (es) 2014-10-28
US10202389B2 (en) 2019-02-12
EP3173413A1 (en) 2017-05-31
US20130217682A1 (en) 2013-08-22
MX2014009944A (es) 2014-11-10
EP3173413B1 (en) 2019-05-01
US9290500B2 (en) 2016-03-22
CA2864672C (en) 2018-01-09
US9663525B2 (en) 2017-05-30
IL234016A0 (en) 2014-09-30
TW201345909A (zh) 2013-11-16
US20160244455A1 (en) 2016-08-25

Similar Documents

Publication Publication Date Title
HK1207078A1 (en) Inhibition of enzymes
HK1201519A1 (en) Inhibitors of phosphodiesterase type 10a 10a
HK1210140A1 (en) Fused pyrimidines as inhibitors of p97 complex p97
HK1206736A1 (en) Seca inhibitors and methods of making and using thereof seca
EP2903613A4 (en) INHIBITORS OF IRAQ4 ACTIVITY
EP2903617A4 (en) INHIBITORS OF IRAQ4 ACTIVITY
AP4029A (en) Inhibitors of beta-secretase
HUE045663T2 (hu) Pteridinek, mint FGFR inhibitorok
HK1201817A1 (en) Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
HK1199252A1 (en) Inhibitors of nedd8-activating enzyme nedd8-
HK1211024A1 (en) Inhibitors of syk syk
IL236963A0 (en) beta-secretase inhibitors
LT2931710T (lt) Piridazinonai kaip daao fermento slopikliai
HK1201066A1 (en) Pyranopyridone inhibitors of tankyrase
PL2888228T3 (pl) Inhibitory oddziaływania CD40-TRAF6
EP2714667A4 (en) AMINOOXAZOLE INHIBITORS OF KINASES DEPENDENT OF CYCLIN
AP2014007697A0 (en) Quinoline derivatives as PDE1OA enzyme inhibitors
GB201312311D0 (en) Uses of enzyme inhibitors
GB201223308D0 (en) Enzyme inhibitors
AU2012905067A0 (en) IMPROVED INHIBITORS OF Grb7